General questions about ASV2020 – asv2020@ColoState.edu
Local Organizing Chair – Jeff Wilusz – 970-491-0652 – Jeffrey.Wilusz@ColoState.edu
Scientific Program Chair – Stephanie Karst – email@example.com
Abstract Submission Assistance – email firstname.lastname@example.org
Conference Registration support – CSU Conference Services – 970-491-6222 – email@example.com
December 2, 2019 – Abstract submission opens
January 13, 2020 – Global Virology Scholar Travel Award application deadline
January 31, 2020 – Abstract submission deadline
February 3, 2020 – Travel Award application deadline
April 17, 2020 – Onsite childcare registration deadline
April 17, 2020 – ASVCares Dependent Care Fellowship application deadline
May 15, 2020 – Registration deadline for regular rates
May 15, 2020 – Cancellation with refund deadline at 5pm MDT (less $75 administrative fee)
May 15, 2020 – On-campus housing reservation deadline
June 1, 2020 – Reservation deadline for Saturday Satellite Symposia
June 1, 2020 – Reservation deadline for Veterinary and Plant Virology Luncheons
June 1, 2020 – Late on-line registration deadline at 5pm MDT ($75 late fee)
June 13, 2020 – On-site registration opens ($150 late fee)
Colorado State University encourages persons with disabilities to participate in its programs and activities. If you anticipate needing special accommodations or have questions about the physical access provided, please note your request on the registration page or contact Conference Services at firstname.lastname@example.org at least two weeks prior to the conference.
ASV Policy on Harassment and Discrimination
The ASV Council takes pride in having the annual meeting be a forum for open scientific discussion from all conference attendees. We are also committed to maintaining an environment that is free from all forms of discrimination and harassment. In support of that, the Council approved a policy on harassment and discrimination in 2018 that clearly states the ASV commitment and informs ASV members of how the policy will be implemented. See the ASV website (“Governance”) for more details.
Funding for this conference was made possible (in part) by R13 AI096720 from the US National Institutes of Health, National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.